Could Daiichi Sankyo have another ADC winner in cancer?
New data point to impressive efficacy in advanced EGFR-mutated non-small cell lung cancer.
Digital health firm Pear considers future as cash dwindles
Company looks at possible sale, merger or licensing deal after making big layoffs last year.
Chasing BMS, Takeda trumpets TYK2 data in psoriasis
Pharma group is hoping for big things, after splashing out $4bn upfront for the drug last year.
AbbVie’s Skyrizi hits the spot in refractory psoriasis
Antibody works when IL-17 inhibitors Like Novartis' Cosentyx and Lilly's Taltz fail.
Dupixent works in hard-to-treat form of atopic dermatitis
IL-4 inhibitor shows its worth in atopic hand-foot dermatitis unresponsive to corticosteroids.
Maximizing Insights At Congresses
In terms of gathering medical insights, congresses are unique for several reasons.
The Challenge Of Finding KOLs For Innovative Therapies
You have a truly innovative medicine with a unique proposition in an area with a clear unmet need
Social Health and Cancer as a Chronic Condition
Data demonstrates the critical role of social health for people living with and beyond cancer
Newel Health begins next phase of development of Soturi
Newel Health's Soturi, a DTx solution for Parkinson’s Disease, begins next phase.
4th Gene Therapy Analytical Development Europe Summit 2023
The definitive and only meeting focused on tackling challenges in gene therapy drug development